Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High-Sensitivity Cardiac Troponin I

American Journal of Medicine

Volumn 130, Issue 12, 2017, Pages 1431-1439.e4

  Sandoval, Yader ^a   Thordsen, Sarah E ^a   Carlson, Michelle D ^a   Johnson, Benjamin K ^a   Smith, Stephen W ^b,c   Bruen, Charles A ^b   Dodd, Kenneth W ^b   Driver, Brian E ^b   Jacoby, Katherine ^b   Moore, Johanna C ^b   Scott, Nathaniel L ^b   Sexter, Anne ^d   Hu, Yan ^d   Love, Sara A ^d,e   Schulz, Karen ^d   Apple, Fred S ^d,e  

^a ABBOTT NORTHWESTERN HOSPITAL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cardiac troponin; Myocardial infarction; Myocardial injury

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HUMAN; HYPERTENSION; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SHOCK; TACHYCARDIA; BLOOD; CLASSIFICATION; COMPARATIVE STUDY; HEART INJURY; INCIDENCE; MIDDLE AGED; PREDICTIVE VALUE;

FEMALE; HEART INJURIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 85027689487     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2017.05.049     Document Type: Article

References (17)

1. Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 60:16 (2012), 1581–1598.
2. Apple, F.S., Sandoval, Y., Jaffe, A.S., Ordonez-Llanos, J., IFCC Task Force on Clinical Applications of Cardiac Bio-Markers. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem 63:1 (2017), 73–81.
3. Sarkisian, L., Saaby, L., Poulsen, T.S., et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med 129:4 (2016), 446.e5–446.e21.
4. Shah, A.S., McAllister, D.A., Mills, R., et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med 128:5 (2015), 493–501.
5. Sandoval, Y., Thordsen, S.E., Smith, S.W., et al. Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk. Eur Heart J Acute Cardiovasc Care 3:4 (2014), 317–325.
6. Saaby, L., Poulsen, T.S., Hosbond, S., et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 126:9 (2013), 789–797.
7. Sandoval, Y., Smith, S.W., Thordsen, S.E., Apple, F.S., Supply/demand type 2 myocardial infarction. J Am Coll Cardiol 63:20 (2014), 2079–2087.
8. Alpert, J.S., Thygesen, K.A., White, H.D., Jaffe, A.S., Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med 127:2 (2014), 105–108.
9. Sandoval, Y., Thygesen, K., Myocardial infarction type 2 and myocardial injury. Clin Chem 63:1 (2017), 101–107.
10. th percentiles based on the third universal definition of myocardial infarction classification system. Clin Chem 61:4 (2015), 657–663.
11. Baron, T., Hambraeus, K., Sundström, J., Erlinge, D., Jernberg, T., Lindahl, B., TOTAL-AMI study group. Type 2 myocardial infarction in clinical practice. Heart 101:2 (2015), 101–106.
12. Love, S.A., Sandoval, Y., Smith, S.W., et al. Incidence of undetectable, measurable, and increased cardiac troponin I concentrations above the 99 percentile using a high-sensitivity vs a contemporary assay in patients presenting to the emergency department. Clin Chem 62:8 (2016), 1115–1119.
13. Meigher, S., Thode, H.C., Peacock, W.F., Bock, J.L., Gruberg, L., Singer, A.J., Causes of elevated cardiac troponins in the emergency department and their associated mortality. Acad Emerg Med 23:11 (2016), 1267–1273.
14. Gaggin, H.K., Liu, Y., Lyass, A., et al. Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography. Circulation 135 (2017), 116–127.
15. Saaby, L., Poulsen, T.S., Diederichsen, A.C., et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med 127 (2014), 295–302.
16. Cediel, G., Gonzalez-Del-Hoyo, M., Carrasquer, A., Sanchez, R., Boqué, C., Bardají, A., Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury. Heart 103:8 (2017), 616–622.
17. Amsterdam, E.A., Wenger, N.K., Brindis, R.G., et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64:24 (2014), e139–e228.